In addition to neurological disorders, DYRK1A dysregulation has been linked to cancer (especially lung and pancreatic cancers), glioblastoma, melanoma, leukemia, diabetes, and heart diseases [78,110,111]. Here, DYRK1A is linked to nervous system disorder.